Natraj Proteins (BSE 530119)₹34.95−4.22%Edible Oil
In the Mar 2026 quarter (standalone), Natraj Proteins reported sales of ₹18.95 Cr, down 18.1% from Mar 2025, and net profit of ₹1.12 Cr, down 11.8% year on year. For the year to Mar 2026, sales were ₹101 Cr and net profit ₹1.01 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 40.74 | 36.38 | 78.35 | 38.99 | 38.63 | 22.87 | 33.51 | 23.14 | 26.64 | 27.01 | 28.87 | 18.95 |
| Expenses | 46.04 | 41.03 | 79.25 | 36.99 | 39.55 | 23.22 | 32.81 | 21.22 | 27.23 | 27.98 | 25.24 | 17.16 |
| Operating Profit | −5.40 | −4.77 | −1.11 | 1.89 | −0.99 | −0.41 | 0.64 | 1.88 | −0.64 | −1.03 | 3.55 | 1.73 |
| OPM % | −13.3% | −13.1% | −1.4% | 4.8% | −2.6% | −1.8% | 1.9% | 8.1% | −2.4% | −3.8% | 12.3% | 9.1% |
| Other Income | 0.04 | 0.06 | 0.04 | 0.20 | 0.06 | 0.07 | 0.03 | 0.36 | 0.08 | 0.06 | 0.05 | 0.11 |
| Interest | 0.67 | 0.78 | 0.56 | 0.94 | 0.73 | 0.54 | 0.51 | 0.65 | 0.56 | 0.59 | 0.58 | 0.65 |
| Depreciation | 0.09 | 0.09 | 0.10 | 0.12 | 0.08 | 0.08 | 0.09 | 0.06 | 0.08 | 0.08 | 0.08 | 0.10 |
| Profit before tax | −6.13 | −5.57 | −1.72 | 1.00 | −1.73 | −0.97 | 0.04 | 1.48 | −1.19 | −1.63 | 2.89 | 1.04 |
| Tax % | 0.2% | 0.2% | 2.3% | 0.0% | 0.0% | 4.1% | 40.0% | 15.5% | 0.8% | 0.6% | 0.3% | −5.7% |
| Net Profit | −6.17 | −5.61 | −1.77 | 1.01 | −1.75 | −1.02 | 0.04 | 1.27 | −1.22 | −1.66 | 2.90 | 1.12 |
| EPS (Rs) | −16.42 | −14.93 | −4.69 | 2.66 | −4.63 | −2.69 | 0.07 | 3.35 | −3.22 | −4.39 | 7.70 | 2.95 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 259 | 197 | 192 | 155 | 147 | 145 | 144 | 195 | 118 | 101 | 101 |
| Expenses | 203 | 254 | 189 | 185 | 150 | 143 | 130 | 140 | 203 | 117 | 98.05 | 97.61 |
| Operating Profit | −2.01 | 4.01 | 6.01 | 6.02 | 5.01 | 3.01 | 14.05 | 3.01 | −9.03 | 1.01 | 4.01 | 3.61 |
| OPM % | −0.9% | 1.5% | 3.3% | 3.1% | 2.9% | 2.1% | 10.0% | 2.2% | −4.8% | 0.9% | 3.6% | 3.6% |
| Other Income | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 |
| Interest | 3.01 | 4.01 | 3.99 | 3.99 | 3.99 | 1.99 | 0.99 | 1.99 | 3.01 | 1.99 | 1.99 | 2.38 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 |
| Profit before tax | −4.99 | 0.00 | 1.99 | 0.99 | 0.00 | 0.99 | 12.97 | 0.99 | −11.97 | −0.99 | 0.99 | 1.11 |
| Tax % | 0.0% | 25.0% | 10.0% | 16.0% | −3.0% | 59.0% | 28.1% | 29.1% | 0.0% | 25.0% | −3.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −5.01 | 0.00 | 2.01 | 1.01 | 0.00 | 0.00 | 9.01 | 1.01 | −13.01 | −1.01 | 1.01 | 1.14 |
| EPS (Rs) | −14.14 | 0.60 | 4.29 | 3.06 | 0.90 | 1.03 | 24.93 | 1.88 | −33.35 | −3.89 | 3.03 | 3.04 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 4.00 | 3.99 |
| Reserves | 33.86 | 28.89 | 28.90 | 30.90 | 31.91 | 31.92 | 31.91 | 41.87 | 41.91 | 29.90 | 27.94 | 29.92 |
| Borrowings | 42.95 | 18.98 | 18.97 | 53.90 | 30.93 | 30.94 | 21.99 | 26.96 | 33.96 | 39.94 | 22.98 | 35.91 |
| Other Liabilities | 15.08 | 19.07 | 14.02 | 18.09 | 6.03 | 4.02 | 10.05 | 3.02 | 9.05 | 4.03 | 4.02 | 7.03 |
| Total Liabilities | 94.88 | 70.93 | 64.88 | 106 | 71.86 | 70.87 | 67.94 | 75.84 | 88.91 | 77.86 | 58.94 | 75.85 |
| Fixed Assets | 6.02 | 5.01 | 4.02 | 4.01 | 4.01 | 3.01 | 3.01 | 4.01 | 4.01 | 5.01 | 5.02 | 6.02 |
| CWIP | 1.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 0.00 | 0.99 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 86.87 | 65.92 | 60.86 | 102 | 68.85 | 67.86 | 65.93 | 70.84 | 82.91 | 71.85 | 51.93 | 69.83 |
| Inventories | 43.88 | 44.93 | 35.90 | 80.78 | 40.88 | 41.90 | 44.90 | 39.90 | 55.84 | 43.87 | 32.92 | 51.92 |
| Trade receivables | 13.98 | 5.99 | 10.99 | 13.98 | 20.01 | 17.99 | 15.01 | 16.99 | 11.99 | 17.01 | 8.99 | 7.99 |
| Cash & equivalents | 19.99 | 6.01 | 3.01 | 0.00 | 4.01 | 2.01 | 0.00 | 5.01 | 2.01 | 0.99 | 0.00 | 0.00 |
| Total Assets | 94.88 | 70.93 | 64.88 | 106 | 71.86 | 70.87 | 67.94 | 75.84 | 88.91 | 77.86 | 58.94 | 75.85 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 25.05 | 9.01 | 3.01 | −37.08 | 30.07 | 2.01 | 9.01 | 6.01 | 3.01 | −6.01 | 22.04 | −14.02 |
| Cash from investing activity | −1.99 | 3.99 | −1.99 | 2.99 | 1.99 | 0.00 | 0.00 | −2.99 | −2.99 | 0.00 | −1.99 | 2.99 |
| Cash from financing activity | −13.01 | −27.02 | −4.01 | 31.04 | −28.05 | −4.01 | −10.01 | 2.01 | −2.01 | 3.01 | −20.03 | 11.01 |
| Net cash flow | 9.96 | −13.95 | −2.99 | −2.99 | 3.98 | −1.99 | −1.99 | 4.98 | −1.99 | −1.99 | −0.99 | 0.00 |
| Capex | 0.45 | 0.05 | 0.00 | 0.00 | 0.49 | 0.17 | 0.00 | 1.87 | 2.15 | 0.10 | 0.76 | 0.22 |
| Free cash flow | 23.99 | 10.99 | 2.99 | −36.93 | 28.97 | 1.99 | 8.99 | 3.99 | 0.99 | −5.99 | 20.99 | −13.99 |
| CFO / OP % | 415.0% | −494.0% | 67.0% | −583.1% | 500.0% | 42.0% | 264.0% | 63.0% | 96.0% | 60.0% | 1,970.0% | −378.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 17 | 11 | 17 | 28 | 39 | 43 | 38 | 44 | 32 | 33 | 29 | 28 |
| Inventory days | 58 | 85 | 55 | 174 | 87 | 108 | 122 | 119 | 154 | 84 | 109 | 207 |
| Days payable | 14 | 23 | 15 | 31 | 7 | 4 | 19 | 2 | 17 | 2 | 3 | 16 |
| Cash conversion cycle | 59 | 71 | 55 | 168 | 117 | 145 | 139 | 159 | 167 | 113 | 133 | 217 |
| Working capital days | 7 | 32 | 27 | 50 | 50 | 68 | 73 | 81 | 82 | 38 | 54 | 70 |
| ROCE % | 7.0% | −3.0% | 8.0% | 9.0% | 7.0% | 6.0% | 4.0% | 21.0% | 4.0% | −12.0% | 2.0% | 6.0% |
For the Mar 2026 quarter, Natraj Proteins reported sales of ₹18.95 Cr, down 18.1% year on year and net profit of ₹1.12 Cr, down 11.8% year on year. The operating margin was 9.1%.
Natraj Proteins' sales for the year to Mar 2026 were ₹101 Cr; over the last twelve months they were ₹101 Cr.
Net profit for the year to Mar 2026 was ₹1.01 Cr, and ₹1.14 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.04.
Natraj Proteins reported borrowings of ₹35.91 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.
Cash from operations was −₹14.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹13.99 Cr.